| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |